These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 22862159)
1. An analysis of the survival rate after radiotherapy in lung cancer patients with bone metastasis: is there an optimal subgroup to be treated with high-dose radiation therapy? Komatsu T; Kunieda E; Oizumi Y; Tamai Y; Akiba T Neoplasma; 2012; 59(6):650-7. PubMed ID: 22862159 [TBL] [Abstract][Full Text] [Related]
2. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases]. Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913 [TBL] [Abstract][Full Text] [Related]
3. [Therapeutic analysis of stereotactic radiotherapy for 39 patients with lung metastasis]. Wu SX; Deng ML; Bao Y; Wang HY; Gao YH; Li FY; Huang SM Ai Zheng; 2006 Jul; 25(7):880-4. PubMed ID: 16831282 [TBL] [Abstract][Full Text] [Related]
4. [Radiation therapy for bone metastasis from hepatocellular carcinoma]. Koom WS; Seong JS; Lee MJ; Park HC; Han KH; Chon JY; Moon YM; Suh CO Taehan Kan Hakhoe Chi; 2002 Sep; 8(3):304-11. PubMed ID: 12499788 [TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients. Kaizu T; Karasawa K; Tanaka Y; Matuda T; Kurosaki H; Tanaka S; Kumazaki T Am J Gastroenterol; 1998 Nov; 93(11):2167-71. PubMed ID: 9820391 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers. Mani S; Todd MB; Katz K; Poo WJ J Urol; 1995 Jul; 154(1):35-40. PubMed ID: 7539867 [TBL] [Abstract][Full Text] [Related]
7. Value of high-dose radiation therapy for isolated osseous metastasis in breast cancer in terms of oligo-recurrence. Niibe Y; Kuranami M; Matsunaga K; Takaya M; Kakita S; Hara T; Sekiguchi K; Watanabe M; Hayakawa K Anticancer Res; 2008; 28(6B):3929-31. PubMed ID: 19192651 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis. Bae HM; Lee SH; Kim TM; Kim DW; Yang SC; Wu HG; Kim YW; Heo DS Lung Cancer; 2012 Sep; 77(3):572-7. PubMed ID: 22672969 [TBL] [Abstract][Full Text] [Related]
9. Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: results on survival in the Dutch Bone Metastasis Study. van der Linden YM; Steenland E; van Houwelingen HC; Post WJ; Oei B; Marijnen CA; Leer JW; Radiother Oncol; 2006 Mar; 78(3):245-53. PubMed ID: 16545474 [TBL] [Abstract][Full Text] [Related]
10. Radiation therapy for metastatic brain tumors from lung cancer--a review to devise individualized treatment plans. Itoh Y; Fuwa N; Morita K Nagoya J Med Sci; 2003 Nov; 66(3-4):119-28. PubMed ID: 14727688 [TBL] [Abstract][Full Text] [Related]
11. Reirradiation with local-field radiotherapy for painful bone metastases. Hayashi S; Hoshi H; Iida T Radiat Med; 2002; 20(5):231-6. PubMed ID: 12450102 [TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme. Quan AL; Barnett GH; Lee SY; Vogelbaum MA; Toms SA; Staugaitis SM; Prayson RA; Peereboom DM; Stevens GH; Cohen BH; Suh JH Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):695-703. PubMed ID: 15936158 [TBL] [Abstract][Full Text] [Related]
13. Results of a surgical resection for patients with stage IV non--small-cell lung cancer. Hanagiri T; Takenaka M; Oka S; Shigematsu Y; Nagata Y; Shimokawa H; Uramoto H; Tanaka F Clin Lung Cancer; 2012 May; 13(3):220-4. PubMed ID: 22138036 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and clinical outcome of patients with lung adenocarcinoma with carcinomatous meningitis. Nakamura Y; Takahashi T; Tsuya A; Naito T; Kenmotsu H; Ono A; Shukuya T; Murakami H; Harada H; Watanabe R; Endo M; Mitsuya K; Nakajima T; Yamamoto N Anticancer Res; 2012 May; 32(5):1811-6. PubMed ID: 22593466 [TBL] [Abstract][Full Text] [Related]
15. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients]. Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471 [TBL] [Abstract][Full Text] [Related]
16. The role of radiotherapy in oseosarcoma. Schwarz R; Bruland O; Cassoni A; Schomberg P; Bielack S Cancer Treat Res; 2009; 152():147-64. PubMed ID: 20213389 [TBL] [Abstract][Full Text] [Related]
17. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms]. Guo GF; Yang AK; Xie RH; Chen ZH; Wu QL; Ou SM; Liu WW; Xia LP; Chen MY; Zhang JX; Wu JH Ai Zheng; 2004 Nov; 23(11 Suppl):1546-50. PubMed ID: 15566677 [TBL] [Abstract][Full Text] [Related]
18. Radiotherapy for painful bone metastases from hepatocellular carcinoma. Seong J; Koom WS; Park HC Liver Int; 2005 Apr; 25(2):261-5. PubMed ID: 15780048 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the prognostic significance of refinement and stratification of distant metastasis status in 1016 cases of nasopharyngeal carcinoma]. Pan CC; Lu J; Chen P; Li X; Jin YD; Zhao M; Xia YF; Wu PH Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):595-9. PubMed ID: 24314217 [TBL] [Abstract][Full Text] [Related]
20. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]